{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:12:20Z","timestamp":1790662340193,"version":"4.1.0"},"reference-count":104,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1210\/jc.2018-01315","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T19:08:24Z","timestamp":1547838504000},"page":"2239-2249","source":"Crossref","is-referenced-by-count":135,"title":["Cognitive Dysfunction in Type 1 Diabetes Mellitus"],"prefix":"10.1210","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1016-0740","authenticated-orcid":false,"given":"Anna","family":"Shalimova","sequence":"first","affiliation":[{"name":"Department of Hypertension and Diabetology, Medical University of Gda\u0144sk, Faculty of Medicine, Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Graff","sequence":"additional","affiliation":[{"name":"Department of Hypertension and Diabetology, Medical University of Gda\u0144sk, Faculty of Medicine, Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"G\u0105secki","sequence":"additional","affiliation":[{"name":"Department of Adult Neurology, Medical University of Gda\u0144sk, Faculty of Medicine, Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Wolf","sequence":"additional","affiliation":[{"name":"Department of Hypertension and Diabetology, Medical University of Gda\u0144sk, Faculty of Medicine, Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Sabisz","sequence":"additional","affiliation":[{"name":"Department of Radiology, Medical University of Gda\u0144sk, Faculty of Medicine, Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edyta","family":"Szurowska","sequence":"additional","affiliation":[{"name":"Department of Radiology, Medical University of Gda\u0144sk, Faculty of Medicine, Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Jodzio","sequence":"additional","affiliation":[{"name":"Institute of Psychology, University of Gda\u0144sk, 80-308 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Narkiewicz","sequence":"additional","affiliation":[{"name":"Department of Hypertension and Diabetology, Medical University of Gda\u0144sk, Faculty of Medicine, Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2019,1,18]]},"reference":[{"key":"2019042418130703600_B1","first-page":"189","author":"Sims-Robinson","year":"2015"},{"key":"2019042418130703600_B2","doi-asserted-by":"crossref","DOI":"10.2337\/dc13-S011","article-title":"Standards of medical care in diabetes\u20142013","volume":"36","author":"American Diabetes Association","year":"2013","journal-title":"Diabetes Care"},{"issue":"1-3","key":"2019042418130703600_B3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejphar.2004.02.052","article-title":"Cerebral glucose metabolism in diabetes mellitus","volume":"490","author":"McCall","year":"2004","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"2019042418130703600_B4","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.2337\/dci16-0026","article-title":"Identifying causes for excess mortality in patients with diabetes: closer but not there yet","volume":"39","author":"Yu","year":"2016","journal-title":"Diabetes Care"},{"issue":"3","key":"2019042418130703600_B5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/1474651410368408","article-title":"Cognitive decline: the relevance of diabetes, hyperlipidaemia and hypertension","volume":"10","author":"Etgen","year":"2010","journal-title":"Br J Diabetes Vasc Dis"},{"issue":"9","key":"2019042418130703600_B6","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","article-title":"Diabetes mellitus and the risk of dementia: the Rotterdam study","volume":"53","author":"Ott","year":"1999","journal-title":"Neurology"},{"issue":"4","key":"2019042418130703600_B7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00592-010-0218-0","article-title":"Encephalopathies: the emerging diabetic complications","volume":"47","author":"Sima","year":"2010","journal-title":"Acta Diabetol"},{"issue":"4","key":"2019042418130703600_B8","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1210\/er.2007-0034","article-title":"Cognitive dysfunction and diabetes mellitus","volume":"29","author":"Kodl","year":"2008","journal-title":"Endocr Rev"},{"issue":"8","key":"2019042418130703600_B9","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1080\/13803390490514875","article-title":"The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function","volume":"26","author":"Awad","year":"2004","journal-title":"J Clin Exp Neuropsychol"},{"issue":"3","key":"2019042418130703600_B10","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.nlm.2011.08.005","article-title":"Brain insulin signaling: a key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes","volume":"96","author":"McNay","year":"2011","journal-title":"Neurobiol Learn Mem"},{"issue":"2","key":"2019042418130703600_B11","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.diabres.2011.07.002","article-title":"Association of cognitive dysfunction with hippocampal atrophy in elderly Japanese people with type 2 diabetes","volume":"94","author":"Hayashi","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"2019042418130703600_B12","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.2337\/dc10-0389","article-title":"Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients","volume":"33","author":"Rizzo","year":"2010","journal-title":"Diabetes Care"},{"issue":"12","key":"2019042418130703600_B13","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1212\/WNL.0b013e31822f0435","article-title":"Glucose tolerance status and risk of dementia in the community: the Hisayama study","volume":"77","author":"Ohara","year":"2011","journal-title":"Neurology"},{"issue":"3","key":"2019042418130703600_B14","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2337\/diacare.28.3.726","article-title":"The effects of type 1 diabetes on cognitive performance: a meta-analysis","volume":"28","author":"Brands","year":"2005","journal-title":"Diabetes Care"},{"issue":"7","key":"2019042418130703600_B15","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/oxfordjournals.aje.a009866","article-title":"Aging successfully until death in old age: opportunities for increasing active life expectancy","volume":"149","author":"Leveille","year":"1999","journal-title":"Am J Epidemiol"},{"issue":"6","key":"2019042418130703600_B16","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.2337\/diacare.28.6.1431","article-title":"Influence of an early-onset age of type 1 diabetes on cerebral structure and cognitive function","volume":"28","author":"Ferguson","year":"2005","journal-title":"Diabetes Care"},{"issue":"5","key":"2019042418130703600_B17","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s00125-015-3515-x","article-title":"Risk of dementia in patients hospitalised with type 1 and type 2 diabetes in England, 1998-2011: a retrospective national record linkage cohort study","volume":"58","author":"Smolina","year":"2015","journal-title":"Diabetologia"},{"issue":"7","key":"2019042418130703600_B18","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1007\/s00125-003-1128-2","article-title":"Cognitive efficiency declines over time in adults with Type 1 diabetes: effects of micro- and macrovascular complications","volume":"46","author":"Ryan","year":"2003","journal-title":"Diabetologia"},{"issue":"1","key":"2019042418130703600_B19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/nyas.12807","article-title":"Impact of diabetes on cognitive function and brain structure","volume":"1353","author":"Moheet","year":"2015","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"2019042418130703600_B20","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00125-007-0615-2","article-title":"School performance in children with type 1 diabetes\u2014a population-based register study","volume":"50","author":"Dahlquist","year":"2007","journal-title":"Diabetologia"},{"issue":"4","key":"2019042418130703600_B21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.pcd.2007.10.002","article-title":"Cognitive dysfunction and diabetes: implications for primary care","volume":"1","author":"Biessels","year":"2007","journal-title":"Prim Care Diabetes"},{"issue":"6","key":"2019042418130703600_B22","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1399-5448.2009.00618.x","article-title":"Neurocognitive functioning in preschool-age children with type 1 diabetes mellitus","volume":"11","author":"Pati\u00f1o-Fern\u00e1ndez","year":"2010","journal-title":"Pediatr Diabetes"},{"issue":"7","key":"2019042418130703600_B23","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.2337\/db14-0348","article-title":"Brain changes underlying cognitive dysfunction in diabetes: what can we learn from MRI","volume":"63","author":"Biessels","year":"2014","journal-title":"Diabetes"},{"issue":"1-2","key":"2019042418130703600_B24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jns.2013.06.019","article-title":"Diabetes mellitus and progression of vascular brain lesions and brain atrophy in patients with symptomatic atherosclerotic disease. The SMART-MR study","volume":"332","author":"Kooistra","year":"2013","journal-title":"J Neurol Sci"},{"issue":"11","key":"2019042418130703600_B25","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1212\/WNL.0b013e3181f25f06","article-title":"Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up","volume":"75","author":"van Elderen","year":"2010","journal-title":"Neurology"},{"issue":"18","key":"2019042418130703600_B26","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1097\/00001756-200212200-00019","article-title":"Loss of temporal lobe beta power in young adults with type 1 diabetes mellitus","volume":"13","author":"Brismar","year":"2002","journal-title":"Neuroreport"},{"issue":"3","key":"2019042418130703600_B27","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s00125-004-1666-2","article-title":"EEG abnormalities with and without relation to severe hypoglycaemia in adolescents with type 1 diabetes","volume":"48","author":"Hyllienmark","year":"2005","journal-title":"Diabetologia"},{"issue":"3","key":"2019042418130703600_B28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1034\/j.1399-5448.2002.30306.x","article-title":"Single photon emission tomography (SPECT) study of regional cerebral blood flow in normoalbuminuric children and adolescents with type 1 diabetes","volume":"3","author":"Salem","year":"2002","journal-title":"Pediatr Diabetes"},{"issue":"11","key":"2019042418130703600_B29","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s002590100595","article-title":"Assessment of cerebral perfusion and cerebrovascular reserve in insulin-dependent diabetic patients without central neurological symptoms by means of 99mTc-HMPAO SPET with acetazolamide","volume":"28","author":"Jim\u00e9nez-Bonilla","year":"2001","journal-title":"Eur J Nucl Med"},{"issue":"9833","key":"2019042418130703600_B30","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/S0140-6736(12)60360-2","article-title":"Diabetes and cognitive dysfunction","volume":"379","author":"McCrimmon","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"2019042418130703600_B31","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2337\/diabetes.55.02.06.db05-0520","article-title":"Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry","volume":"55","author":"Musen","year":"2006","journal-title":"Diabetes"},{"issue":"3","key":"2019042418130703600_B32","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2337\/dc08-1657","article-title":"Central nervous system function in youth with type 1 diabetes 12 years after disease onset","volume":"32","author":"Northam","year":"2009","journal-title":"Diabetes Care"},{"issue":"12","key":"2019042418130703600_B33","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s002590050181","article-title":"Semi-quantitative assessment of cerebral blood flow with 99mTc-HMPAO SPET in type I diabetic patients with no clinical history of cerebrovascular disease","volume":"24","author":"Quirce","year":"1997","journal-title":"Eur J Nucl Med"},{"issue":"9","key":"2019042418130703600_B34","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.2337\/dc14-0016","article-title":"Ventral striatum, but not cortical volume loss, is related to cognitive dysfunction in type 1 diabetic patients with and without microangiopathy","volume":"37","author":"van Duinkerken","year":"2014","journal-title":"Diabetes Care"},{"issue":"7","key":"2019042418130703600_B35","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3174\/ajnr.A2464","article-title":"Diffusion-weighted imaging of hyperacute cerebral hypoglycemia","volume":"32","author":"Schmidt","year":"2011","journal-title":"AJNR Am J Neuroradiol"},{"key":"2019042418130703600_B36","author":"Gallardo-Moreno","year":"2015"},{"key":"2019042418130703600_B37","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fneur.2018.00092","article-title":"Understanding the physiopathology behind axial and radial diffusivity changes\u2014what do we know","volume":"9","author":"Winklewski","year":"2018","journal-title":"Front Neurol"},{"issue":"5","key":"2019042418130703600_B38","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3174\/ajnr.A1052","article-title":"Diffusion tensor MR imaging and fiber tractography: technical considerations","volume":"29","author":"Mukherjee","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"issue":"11","key":"2019042418130703600_B39","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.2337\/db08-0724","article-title":"Diffusion tensor imaging identifies deficits in white matter microstructure in subjects with type 1 diabetes that correlate with reduced neurocognitive function","volume":"57","author":"Kodl","year":"2008","journal-title":"Diabetes"},{"issue":"4","key":"2019042418130703600_B40","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1007\/s00125-012-2488-2","article-title":"Diffusion tensor imaging in type 1 diabetes: decreased white matter integrity relates to cognitive functions","volume":"55","author":"van Duinkerken","year":"2012","journal-title":"Diabetologia"},{"issue":"1059","key":"2019042418130703600_B41","doi-asserted-by":"crossref","first-page":"20150680","DOI":"10.1259\/bjr.20150680","article-title":"Relationships of DTI findings with neurocognitive dysfunction in children with Type 1 diabetes mellitus","volume":"89","author":"Toprak","year":"2016","journal-title":"Br J Radiol"},{"issue":"8","key":"2019042418130703600_B42","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s00125-007-0714-0","article-title":"Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volume","volume":"50","author":"Wessels","year":"2007","journal-title":"Diabetologia"},{"issue":"3","key":"2019042418130703600_B43","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00125-007-0904-9","article-title":"The effects of type 1 diabetes on cerebral white matter","volume":"51","author":"Weinger","year":"2008","journal-title":"Diabetologia"},{"issue":"8","key":"2019042418130703600_B44","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1161\/01.STR.0000135226.53499.85","article-title":"Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study","volume":"35","author":"Jeerakathil","year":"2004","journal-title":"Stroke"},{"key":"2019042418130703600_B45","author":"Nunley","year":"2015"},{"issue":"4","key":"2019042418130703600_B46","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/dc13-1586","article-title":"Proliferative retinopathy in type 1 diabetes is associated with cerebral microbleeds, which is part of generalized microangiopathy","volume":"37","author":"Woerdeman","year":"2014","journal-title":"Diabetes Care"},{"issue":"5","key":"2019042418130703600_B47","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1007\/s11682-016-9583-9","article-title":"Cerebral perfusion alterations in type 2 diabetes and its relation to insulin resistance and cognitive dysfunction","volume":"11","author":"Cui","year":"2017","journal-title":"Brain Imaging Behav"},{"issue":"1","key":"2019042418130703600_B48","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/ageing\/afp211","article-title":"Pathophysiology of cognitive dysfunction in older people with type 2 diabetes: vascular changes or neurodegeneration","volume":"39","author":"Umegaki","year":"2010","journal-title":"Age Ageing"},{"issue":"1","key":"2019042418130703600_B49","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejphar.2007.11.080","article-title":"Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes","volume":"585","author":"Wessels","year":"2008","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"2019042418130703600_B50","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2337\/dc16-1229","article-title":"Cognitive dysfunction in older adults with diabetes: what a clinician needs to know","volume":"40","author":"Munshi","year":"2017","journal-title":"Diabetes Care"},{"issue":"6","key":"2019042418130703600_B51","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2337\/dc08-1722","article-title":"Cognitive function is disrupted by both hypo- and hyperglycemia in school-aged children with type 1 diabetes: a field study","volume":"32","author":"Gonder-Frederick","year":"2009","journal-title":"Diabetes Care"},{"issue":"2","key":"2019042418130703600_B52","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1464-5491.2010.03199.x","article-title":"R D Lawrence Lecture 2010. The brain as a target organ in type 2 diabetes: exploring the links with cognitive impairment and dementia","volume":"28","author":"Strachan","year":"2011","journal-title":"Diabet Med"},{"issue":"18","key":"2019042418130703600_B53","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJMoa066397","article-title":"Long-term effect of diabetes and its treatment on cognitive function","volume":"356","author":"Jacobson","year":"2007","journal-title":"N Engl J Med"},{"key":"2019042418130703600_B54","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.bbr.2014.08.033","article-title":"Hyperglycemia induces memory impairment linked to increased acetylcholinesterase activity in zebrafish (Danio rerio)","volume":"274","author":"Capiotti","year":"2014","journal-title":"Behav Brain Res"},{"issue":"2","key":"2019042418130703600_B55","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neulet.2012.01.014","article-title":"Cognitive dysfunction associated with diabetic ketoacidosis in rats","volume":"510","author":"Glaser","year":"2012","journal-title":"Neurosci Lett"},{"issue":"14","key":"2019042418130703600_B56","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1001\/jamainternmed.2013.6176","article-title":"Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus","volume":"173","author":"Yaffe","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"8","key":"2019042418130703600_B57","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.2337\/dc09-0212","article-title":"Effects of acute insulin-induced hypoglycemia on spatial abilities in adults with type 1 diabetes","volume":"32","author":"Wright","year":"2009","journal-title":"Diabetes Care"},{"issue":"1","key":"2019042418130703600_B58","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1464-5491.2005.01795.x","article-title":"Attentional functioning is impaired during acute hypoglycaemia in people with type 1 diabetes","volume":"23","author":"McAulay","year":"2006","journal-title":"Diabet Med"},{"issue":"3","key":"2019042418130703600_B59","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/BF00404042","article-title":"Permanent neuropsychological impairment after recurrent episodes of severe hypoglycaemia in man","volume":"33","author":"Wredling","year":"1990","journal-title":"Diabetologia"},{"issue":"5","key":"2019042418130703600_B60","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00405006","article-title":"Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus","volume":"34","author":"Langan","year":"1991","journal-title":"Diabetologia"},{"issue":"10","key":"2019042418130703600_B61","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.2337\/dc08-0607","article-title":"Impact of diabetes and its treatment on cognitive function among adolescents who participated in the Diabetes Control and Complications Trial","volume":"31","author":"Musen","year":"2008","journal-title":"Diabetes Care"},{"issue":"12","key":"2019042418130703600_B62","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s001250050602","article-title":"Complications in IDDM are caused by elevated blood glucose level: the Stockholm Diabetes Intervention Study (SDIS) at 10-year follow up","volume":"39","author":"Reichard","year":"1996","journal-title":"Diabetologia"},{"issue":"2","key":"2019042418130703600_B63","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00125-010-1883-9","article-title":"Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the Diabetes Control and Complications Trial (DCCT) cohort","volume":"54","author":"Jacobson","year":"2011","journal-title":"Diabetologia"},{"issue":"10","key":"2019042418130703600_B64","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.2337\/db15-1653","article-title":"Nrf2-mediated neuroprotection against recurrent hypoglycemia is insufficient to prevent cognitive impairment in a rodent model of type 1 diabetes","volume":"65","author":"McNeilly","year":"2016","journal-title":"Diabetes"},{"issue":"19","key":"2019042418130703600_B65","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1001\/archinte.168.19.2070","article-title":"Cardiovascular outcomes in trials of oral diabetes medications: a systematic review","volume":"168","author":"Selvin","year":"2008","journal-title":"Arch Intern Med"},{"issue":"1-2","key":"2019042418130703600_B66","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jns.2010.08.057","article-title":"Diabetes type 2, hypertension and cognitive dysfunction in middle age women","volume":"299","author":"Petrova","year":"2010","journal-title":"J Neurol Sci"},{"issue":"1","key":"2019042418130703600_B67","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3233\/JAD-161250","article-title":"Type 1 diabetes mellitus and cognitive impairments: a systematic review","volume":"57","author":"Li","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"2019042418130703600_B68","first-page":"263","article-title":"Cognitive dysfunction in diabetic patients with special reference to age of onset, duration and control of diabetes","volume":"54","author":"Mukherjee","year":"2012","journal-title":"Act Nerv Super"},{"issue":"1","key":"2019042418130703600_B69","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2337\/diabetes.52.1.149","article-title":"Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia","volume":"52","author":"Ferguson","year":"2003","journal-title":"Diabetes"},{"issue":"5","key":"2019042418130703600_B70","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/dmrr.2507","article-title":"Diabetes, dysglycemia and cognitive dysfunction","volume":"30","author":"Cukierman-Yaffe","year":"2014","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"2019042418130703600_B71","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2337\/dc17-S014","article-title":"Older adults. Sec. 11. In Standards of Medical Care in Diabetes 2017","volume":"40","author":"American Diabetes Association","year":"2017","journal-title":"Diabetes Care"},{"key":"2019042418130703600_B72","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fnagi.2013.00064","article-title":"Roles of vascular and metabolic components in cognitive dysfunction of Alzheimer disease: short- and long-term modification by non-genetic risk factors","volume":"5","author":"Sato","year":"2013","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"2019042418130703600_B73","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00125-007-0894-7","article-title":"Predictors of cognitive impairment and dementia in older people with diabetes","volume":"51","author":"Bruce","year":"2008","journal-title":"Diabetologia"},{"issue":"1","key":"2019042418130703600_B74","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2337\/db06-0879","article-title":"The effect of borderline diabetes on the risk of dementia and Alzheimer\u2019s disease","volume":"56","author":"Xu","year":"2007","journal-title":"Diabetes"},{"key":"2019042418130703600_B75","doi-asserted-by":"crossref","first-page":"8678539","DOI":"10.1155\/2018\/8678539","article-title":"Prophylactic use of troxerutin can delay the development of diabetic cognitive dysfunction and improve the expression of Nrf2 in the hippocampus on STZ diabetic rats","volume":"2018","author":"Zhang","year":"2018","journal-title":"Behav Neurol"},{"key":"2019042418130703600_B76","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.biopha.2017.10.138","article-title":"Resistance training and hawthorn extract ameliorate cognitive deficits in streptozotocin-induced diabetic rats","volume":"97","author":"Zarrinkalam","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"2019042418130703600_B77","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11011-011-9262-x","article-title":"Effects of physical exercise on spatial memory and astroglial alterations in the hippocampus of diabetic rats","volume":"26","author":"de Senna","year":"2011","journal-title":"Metab Brain Dis"},{"issue":"3","key":"2019042418130703600_B78","first-page":"252","article-title":"[Different subtypes of estrogen receptor \u03b1 and related signal molecules in the hippocampus are associated with spatial cognitive impairment of diabetic mice]","volume":"69","author":"Zhang","year":"2017","journal-title":"Sheng Li Xue Bao"},{"issue":"6","key":"2019042418130703600_B79","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s11906-013-0398-4","article-title":"Hypertension, brain damage and cognitive decline","volume":"15","author":"G\u0105secki","year":"2013","journal-title":"Curr Hypertens Rep"},{"issue":"1-3","key":"2019042418130703600_B80","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ejphar.2004.02.054","article-title":"The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations","volume":"490","author":"Allen","year":"2004","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"2019042418130703600_B81","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1007\/s00125-005-0023-4","article-title":"Cognitive decline and dementia in diabetes\u2014systematic overview of prospective observational studies","volume":"48","author":"Cukierman","year":"2005","journal-title":"Diabetologia"},{"issue":"15","key":"2019042418130703600_B82","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1002\/jnr.21787","article-title":"Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer\u2019s disease and correction by insulin","volume":"86","author":"Jolivalt","year":"2008","journal-title":"J Neurosci Res"},{"issue":"2","key":"2019042418130703600_B83","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.expneurol.2009.11.005","article-title":"Type 1 diabetes exaggerates features of Alzheimer\u2019s disease in APP transgenic mice","volume":"223","author":"Jolivalt","year":"2010","journal-title":"Exp Neurol"},{"key":"2019042418130703600_B84","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.neuroscience.2011.11.032","article-title":"Similar pattern of peripheral neuropathy in mouse models of type 1 diabetes and Alzheimer\u2019s disease","volume":"202","author":"Jolivalt","year":"2012","journal-title":"Neuroscience"},{"issue":"15","key":"2019042418130703600_B85","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.1523\/JNEUROSCI.4640-14.2016","article-title":"Brain-wide insulin resistance, tau phosphorylation changes, and hippocampal neprilysin and amyloid-\u03b2 alterations in a monkey model of type 1 diabetes","volume":"36","author":"Morales-Corraliza","year":"2016","journal-title":"J Neurosci"},{"issue":"10","key":"2019042418130703600_B86","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1007\/s00125-014-3333-6","article-title":"Cerebrospinal fluid levels of Alzheimer\u2019s disease biomarkers in middle-aged patients with type 1 diabetes","volume":"57","author":"Ouwens","year":"2014","journal-title":"Diabetologia"},{"issue":"7","key":"2019042418130703600_B87","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jalz.2018.01.016","article-title":"Effects of APOE-\u03b54 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer\u2019s disease","volume":"14","author":"Cacciaglia","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"1","key":"2019042418130703600_B88","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1476-511X-13-47","article-title":"Apolipoprotein E gene polymorphism and the risk of intracerebral hemorrhage: a meta-analysis of epidemiologic studies","volume":"13","author":"Zhang","year":"2014","journal-title":"Lipids Health Dis"},{"key":"2019042418130703600_B89","author":"Montufar"},{"issue":"4","key":"2019042418130703600_B90","doi-asserted-by":"crossref","first-page":"832.e15","DOI":"10.1016\/j.neurobiolaging.2011.07.016","article-title":"APOE \u03b54 differentially influences change in memory performance depending on age. The SMART-MR study","volume":"33","author":"Jochemsen","year":"2012","journal-title":"Neurobiol Aging"},{"issue":"10","key":"2019042418130703600_B91","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.biopsych.2008.07.004","article-title":"Decreased cognition in children with risk factors for Alzheimer\u2019s disease","volume":"64","author":"Bloss","year":"2008","journal-title":"Biol Psychiatry"},{"key":"2019042418130703600_B92","doi-asserted-by":"crossref","first-page":"726197","DOI":"10.4061\/2011\/726197","article-title":"The apolipoprotein e antagonistic pleiotropy hypothesis: review and recommendations","volume":"2011","author":"Tuminello","year":"2011","journal-title":"Int J Alzheimers Dis"},{"issue":"2","key":"2019042418130703600_B93","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"2019042418130703600_B94","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.bbadis.2016.08.018","article-title":"Is Alzheimer\u2019s disease a type 3 diabetes? A critical appraisal","volume":"1863","author":"Kandimalla","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"11","key":"2019042418130703600_B95","first-page":"2263","article-title":"Guidelines for managing Alzheimer\u2019s disease: part I. Assessment","volume":"65","author":"Cummings","year":"2002","journal-title":"Am Fam Physician"},{"issue":"4","key":"2019042418130703600_B96","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"2019042418130703600_B97","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1474-4422(08)70021-8","article-title":"Cognition and diabetes: a lifespan perspective","volume":"7","author":"Biessels","year":"2008","journal-title":"Lancet Neurol"},{"issue":"12","key":"2019042418130703600_B98","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/archinte.164.12.1327","article-title":"Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort","volume":"164","author":"Kanaya","year":"2004","journal-title":"Arch Intern Med"},{"issue":"10","key":"2019042418130703600_B99","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrneurol.2010.130","article-title":"How does diabetes accelerate Alzheimer disease pathology","volume":"6","author":"Sims-Robinson","year":"2010","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"2019042418130703600_B100","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1474-4422(05)70284-2","article-title":"Risk of dementia in diabetes mellitus: a systematic review","volume":"5","author":"Biessels","year":"2006","journal-title":"Lancet Neurol"},{"key":"2019042418130703600_B101","author":"Niedowicz","year":"2014"},{"issue":"12","key":"2019042418130703600_B102","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.2337\/dc13-1501","article-title":"Brain MRI correlates of cognitive dysfunction in type 2 diabetes: the needle recovered from the haystack","volume":"36","author":"Biessels","year":"2013","journal-title":"Diabetes Care"},{"issue":"4","key":"2019042418130703600_B103","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.3233\/JAD-160504","article-title":"Five-year longitudinal brain volume change in healthy elders at genetic risk for Alzheimer\u2019s disease","volume":"55","author":"Reiter","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"2019042418130703600_B104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0024643","article-title":"Guidelines for the evaluation of dementia and age-related cognitive change","volume":"67","author":"American Psychological Association","year":"2012","journal-title":"Am Psychol"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/104\/6\/2239\/28521355\/jc.2018-01315.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T06:17:20Z","timestamp":1720937840000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/104\/6\/2239\/5290155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,18]]},"references-count":104,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,1,18]]},"published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2018-01315","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6]]},"published":{"date-parts":[[2019,1,18]]}}}